Galatea Bio Launches StrataRisk™ Polygenic Risk Score to Scale Common Disease Risk Assessment and Reporting at the 2025 ACMG Conference
“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
Pivotal Phase 3 OPERA-01 trial of palazestrant as a monotherapy in patients with 2/3L metastatic breast cancer on track for top-line data in ...
Schumer and Senate Democrats had two bad choices. Did they pick right?
Regarding the March 15 front-page article “ Democratic split widens as Senate averts shutdown ”: ...
A 26-year-old with stomach pain was getting checked for celiac disease. It turned out to be stage 4 colon cancer.
Shannin Desroches was diagnosed with stage 4 colon cancer. She had no symptoms for years, experiencing a nagging pain only ...
Scientific Research Publishing3h
Enhancing Prediction of Osteoporosis Using Supervised and Unsupervised Learning: New Approach to Disease Subtyping ()
Background: Osteoporosis is a serious health issue that can lead to severe clinical diseases, involving fractures. The ...